Brucellosis and its particularities in children travelers
- Mile Bosilkovski,
- Alfonso J. Rodriguez-Morales(corresponding author)
- SS Cyril and Methodius University,
- International Society of Chemotherapy,
- Universidad Tecnológica de Pereira,
- Latin American Society for Travel Medicine (SLAMVI),
- Colombian Association of Infectious Diseases (Asociación Colombiana de Infectologia, ACIN)
Research Output:
Contribution to journal
Article
Peer-reviewPublication Information
Output type
Research Output:
Contribution to journal
Article
Peer-reviewOriginal language
EnglishPages from-to (Number of pages)
Pages 164-172 (9 pages)Journal (Volume, Issue Number)
Recent Patents on Anti-Infective Drug Discovery (Volume 9, Issue 3)Publication milestones
- Published - 01/06/2015
Publication status
Published - 01/06/2015
ISSN
1574-891XPublication IDs
- Scopus: 84953344641
- PubMed: 25851430
- Scopus: 84930510755
Abstract
Brucellosis is still endemic in many countries in the world, however, having a significantly higher incidence in developing countries. As consequence of travel, risk for children from non-endemic areas would be considerable when visiting developing countries. Then, the purpose of this review is to provide, after a bibliographical search, an update on the main aspects of this disease in the traveler children. For the general practitioner, but particularly for travel medicine practitioner and pediatricians, these clinicoepidemiological considerations should be taken in mind in the differential diagnosis when assessing children returning from travel to brucellosis endemic areas.
Publication metrics
Metrics
PlumX, opens in new tab
Captures
19
Citations
15
Sustainable Development Goals
- SDG 3 Good Health and Well
